Growing community of inventors

Perkasie, PA, United States of America

William L Laswell

Average Co-Inventor Count = 4.61

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 94

William L LaswellGeorge D Hartman (5 patents)William L LaswellMark E Duggan (5 patents)William L LaswellRalph P Volante (5 patents)William L LaswellMelissa S Egbertson (5 patents)William L LaswellIchiro Shinkai (5 patents)William L LaswellWasyl Halczenko (5 patents)William L LaswellJoseph E Lynch (5 patents)William L LaswellDavid M Tschaen (1 patent)William L LaswellLaura M Turchi (1 patent)William L LaswellWilliam L Laswell (10 patents)George D HartmanGeorge D Hartman (183 patents)Mark E DugganMark E Duggan (79 patents)Ralph P VolanteRalph P Volante (70 patents)Melissa S EgbertsonMelissa S Egbertson (49 patents)Ichiro ShinkaiIchiro Shinkai (48 patents)Wasyl HalczenkoWasyl Halczenko (47 patents)Joseph E LynchJoseph E Lynch (34 patents)David M TschaenDavid M Tschaen (31 patents)Laura M TurchiLaura M Turchi (5 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck + Co., Inc. (10 from 4,770 patents)


10 patents:

1. 6040317 - Sulfonamide fibrinogen receptor antagonists

2. 5880136 - Sulfonamide fibrinogen receptor antagonists

3. 5814643 - Sulfonamide fibrinogen receptor antagonists

4. 5658929 - Sulfonamide fibrinogen receptor antagonists

5. 5294616 - Fibrinogen receptor antagonists

6. 5177201 - Nitrogen deprotected 4-acyloxyazetidin-2-ones

7. 5145957 - Stereoselective synthesis of a chiral cis 3-beta hydrogen (3R)

8. 4952288 - Process for the preparation of 4-acyloxyazetidin-2-one by

9. 4940520 - Process for the preparation of 4-acyloxyazetidin-2-one by singlet oxygen

10. 4923982 - Oxidation and reduction method to produce 4-acyloxyazetidin-2-one

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…